871PKEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)
Frede Donskov,David F. McDermott,Jong Lyul Lee,Cezary Szczylik,J. Malik,Boris Y. Alekseev,James Larkin,Vsevolod Matveev,R Airatovich Gafanov,Piotr Tomczak,Scott S. Tykodi,Poul F. Geertsen,Paweł Wiechno,Sang Jun Shin,Frédéric Pouliot,T. Alonso Gordoa, R Kloss Silverman,Rodolfo F. Perini,Charles Schloss,Michael B. Atkins ANNALS OF ONCOLOGY(2018)
AI 理解论文
溯源树
样例